AN OPEN‐LABEL, PHASE 1/2 STUDY OF FRONTLINE BRENTUXIMAB VEDOTIN + ADRIAMYCIN, VINBLASTINE, AND DACARBAZINE IN PAEDIATRIC PATIENTS WITH ADVANCED STAGE HODGKIN LYMPHOMA. (17th June 2021) - Franklin, A.R.K; Luisi, F. A. V; Pianovski, M. A; Salvino, M. A; Fagioli, F; Epelman, S; B De Abreu Lima, L; Norris, R. E.; Odone‐Filho, V; Zecca, M; Favre, C; Kobayashi, R; et al.